dr. patel discusses zanubrutinib in mcl
Published 5 years ago • 389 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:45
dr. patel discusses promise of acalabrutinib in mcl
-
0:58
dr. leslie on the benefits with zanubrutinib in mcl
-
1:29
dr. leslie on the role of zanubrutinib in mcl
-
1:32
dr. zelenetz on zanubrutinib research in mcl
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl
-
0:59
dr. rule on the fda approval of zanubrutinib in mcl
-
1:22
dr. leslie on sequencing zanubrutinib in mcl
-
0:44
dr. tam on zanubrutinib approval in mcl
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
11:26
marginal zone b-cell lymphoma (maltoma) - indolent b-cell non-hodgkin’s lymphoma - hematology/ onco
-
1:16:16
#hemepath diffuse large b-cell lymphoma: an update
-
2:40
successful use of zanubrutinib for r/r mcl in china
-
1:08
dr. song on zanubrutinib activity in relapsed/refractory mcl
-
1:57
dr. patel on ibrutinib in real-world setting versus clinical trials
-
1:02
dr. tam on zanubrutinib vs ibrutinib research in mantle cell lymphoma
-
2:00
dr. goy discusses btk inhibitors in mcl
-
1:03
dr. maddocks on the role of zanubrutinib in b-cell malignancies
-
0:54
dr. wang on updated data with single-agent acalabrutinib in mcl
-
1:27
dr. patel on induction in patients with mantle cell lymphoma
-
1:23
dr. rule on the future treatment paradigm in mcl
-
5:00
beigene’s brukinsa (zanubrutinib): a newly approved treatment medicine for mantle cell lymphoma (mcl
-
1:35
dr. trotman discusses zanubrutinib in waldenstrom's macroglobulinemia